Osaic Holdings’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Osaic Holdings’s Portfolio XPH Stock Details XPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$392K	Buy	5,909 +952	+19%	+$55.8K	﹤0.01%	3868
2026 Q1	$268K	Sell	4,957 -986	-17%	-$55K	﹤0.01%	3899
2025 Q4	$333K	Sell	5,943 -7,927	-57%	-$411K	﹤0.01%	3701
2025 Q3	$663K	Buy	13,870 +9,004	+185%	+$403K	﹤0.01%	3187
2025 Q2	$198K	Buy	4,866 +146	+3%	+$5.87K	﹤0.01%	3954
2025 Q1	$207K	Buy	4,720 +78	+2%	+$3.44K	﹤0.01%	3599
2024 Q4	$200K	Sell	4,642 -2,572	-36%	-$117K	﹤0.01%	3597
2024 Q3	$320K	Sell	7,214 -245	-3%	-$10.5K	﹤0.01%	3259
2024 Q2	$297K	Buy	7,459 +488	+7%	+$19.8K	﹤0.01%	3231
2024 Q1	$301K	Buy	6,971 +675	+11%	+$29.1K	﹤0.01%	3340
2023 Q4	$262K	Buy	6,296 +118	+2%	+$4.47K	﹤0.01%	3700
2023 Q3	$246K	Buy	6,178 +399	+7%	+$16.9K	﹤0.01%	3849
2023 Q2	$237K	Sell	5,779 -1,125	-16%	-$46.5K	﹤0.01%	3754
2023 Q1	$284K	Buy	6,904 +257	+4%	+$10.8K	﹤0.01%	3595
2022 Q4	$272K	Buy	6,647 +2,910	+78%	+$121K	﹤0.01%	3588
2022 Q3	$150K	Sell	3,737 -18,511	-83%	-$792K	﹤0.01%	4020
2022 Q2	$935K	Buy	22,248 +17,340	+353%	+$727K	﹤0.01%	2343
2022 Q1	$222K	Sell	4,908 -136	-3%	-$5.98K	﹤0.01%	3946
2021 Q4	$233K	Sell	5,044 -842	-14%	-$39.9K	﹤0.01%	3810
2021 Q3	$280K	Buy	5,886 +1,667	+40%	+$82.8K	﹤0.01%	3608
2021 Q2	$218K	Sell	4,219 -9,488	-69%	-$476K	﹤0.01%	3799
2021 Q1	$691K	Buy	13,707 +1,987	+17%	+$106K	﹤0.01%	2551
2020 Q4	$610K	Buy	11,720 +6,420	+121%	+$307K	﹤0.01%	2462
2020 Q3	$230K	Buy	5,300 +2,000	+61%	+$87.6K	﹤0.01%	3107
2020 Q2	$141K	Sell	3,300 -710	-18%	-$29.3K	﹤0.01%	3426
2020 Q1	$145K	Buy	+4,010	New	+$171K	﹤0.01%	3159

Other funds holding XPH

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

KWM

Kingsview Wealth Management Grants Pass, Oregon $8.25B AUM 24.8% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

FCBT

First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return

Envestnet Portfolio Solutions Chicago, Illinois $20.9B AUM 19.34% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Evelyn Partners London $46.9B AUM

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Osaic Holdings's XPH Position: Q2 2026 in Review

Osaic Holdings increased its State Street SPDR S&P Pharmaceuticals ETF (XPH) stake by 19% in Q2 2026, buying an estimated $55.8K and bringing the position to 5,909 shares worth $392K. The position accounts for ﹤0.01% of the portfolio, ranked #3868.

Osaic Holdings first reported a position in XPH in Q1 2020 and has held it in 26 quarters since. The position peaked at $935K in Q2 2022. 93 funds tracked by Wall St. Rank hold XPH as of Q2 2026.

Osaic Holdings held 5,909 shares of State Street SPDR S&P Pharmaceuticals ETF worth $392K as of Q2 2026.
Osaic Holdings bought 952 State Street SPDR S&P Pharmaceuticals ETF shares in Q2 2026, an estimated $55.8K.
State Street SPDR S&P Pharmaceuticals ETF made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #3868 holding.
Osaic Holdings first reported a position in State Street SPDR S&P Pharmaceuticals ETF in Q1 2020 and has held it in 26 quarters since.
Osaic Holdings's State Street SPDR S&P Pharmaceuticals ETF position peaked at $935K in Q2 2022.
93 funds tracked by Wall St. Rank held State Street SPDR S&P Pharmaceuticals ETF as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.